Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST) (SSGXVIII/AIO) |
|||
| Conditions: | GIST Sarcoma | |||
Trial Status: |
Completed |
|||
Helsinki University Central Hospital |
Principal Investigator: |
Heikki Joensuu, MD |
|---|---|
Contact: |
ia Viskari, +358-9-4711, mia.viskari@hus.fi |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Helsinki University Central Hospital Website: |
http://www.hus.fi/default.asp?path=59 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.